Skip to content
★ Sign in to follow
OS

Otto Skolling

Asarina Pharma AB
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€42k
▼ Sales (0 ops.)
—

Latest filing published 21 Feb 2020 for Asarina Pharma AB, €6,626.

Filing timeline

BuySale
Otto Skolling

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Otto Skolling: trading record in brief

Otto Skolling discloses dealings in Asarina Pharma AB to Finansinspektionen. The record holds 3 filings, for trades running from 18 September 2018 to 21 February 2020.

Purchases make up the whole of the open-market record (3 purchases, €42k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2020, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €6,626. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 21 February 2020, the filings show an open-market purchase worth €6,626 in Asarina Pharma AB. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Otto Skolling

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    CBOExecutivesAsarina Pharma AB
    70,175 SEK35FI-SE
    2,005 shares@ SEK 35.0058.1% of flowAktieISIN SE0011641794FI:csv-e96969d1fb8a4da4155c
    Canonical exit: 21 May 2020 (T+90)
  • ▲
    CBOExecutivesAsarina Pharma AB
    51,000 SEK27FI-SE
    2,000 shares@ SEK 25.5041.9% of flowAktieISIN SE0011641794FI:csv-0f9a33977156a67c72f3
    Canonical exit: 23 Dec 2019 (T+90)
  • ▲
    Chief Business OfficerExecutivesAsarina Pharma AB
    315,000 SEK31FI-SE
    15,000 shares@ SEK 21.00100.0% of flowAktieISIN SE0011641794FI:csv-39173f0f49d5dead3b18
    Canonical exit: 17 Dec 2018 (T+90)

3 of 3 declarations